Family Capital Trust’s Pfizer PFE Stock Holding History

Family Capital Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,200	Closed	-$264K	–	57
2023 Q2	$264K	Hold	7,200	–	–	0.09%	41
2023 Q1	$294K	Hold	7,200	–	–	0.11%	40
2022 Q4	$369K	Hold	7,200	–	–	0.15%	34
2022 Q3	$315K	Hold	7,200	–	–	0.14%	36
2022 Q2	$377K	Hold	7,200	–	–	0.15%	35
2022 Q1	$373K	Hold	7,200	–	–	0.12%	39
2021 Q4	$425K	Hold	7,200	–	–	0.12%	36
2021 Q3	$310K	Hold	7,200	–	–	0.09%	37
2021 Q2	$282K	Hold	7,200	–	–	0.08%	40
2021 Q1	$261K	Hold	7,200	–	–	0.08%	39
2020 Q4	$265K	Sell	7,200 -389	-5%	-$14.3K	0.08%	38
2020 Q3	$264K	Hold	7,589	–	–	0.09%	38
2020 Q2	$235K	Hold	7,589	–	–	0.08%	41
2020 Q1	$241K	Hold	7,589	–	–	0.09%	40
2019 Q4	$282K	Hold	7,589	–	–	0.11%	40
2019 Q3	$259K	Hold	7,589	–	–	0.11%	39
2019 Q2	$312K	Hold	7,589	–	–	0.13%	36
2019 Q1	$306K	Hold	7,589	–	–	0.13%	37
2018 Q4	$314K	Hold	7,589	–	–	0.15%	35
2018 Q3	$317K	Hold	7,589	–	–	0.13%	37
2018 Q2	$261K	Hold	7,589	–	–	0.12%	37
2018 Q1	$255K	Hold	7,589	–	–	0.12%	37
2017 Q4	$261K	Buy	7,589 +3,900	+106%	+$133K	0.12%	37
2017 Q3	$125K	Hold	3,689	–	–	0.06%	43
2017 Q2	$118K	Hold	3,689	–	–	0.06%	42
2017 Q1	$119K	Hold	3,689	–	–	0.06%	43
2016 Q4	$114K	Hold	3,689	–	–	0.07%	46
2016 Q3	$119K	Hold	3,689	–	–	0.07%	46
2016 Q2	$123K	Hold	3,689	–	–	0.07%	45
2016 Q1	$104K	Sell	3,689 -7,294	-66%	-$208K	0.06%	46
2015 Q4	$336K	Hold	10,983	–	–	0.18%	35
2015 Q3	$327K	Sell	10,983 -527	-5%	-$16.9K	0.19%	35
2015 Q2	$366K	Buy	11,510 +443	+4%	+$14.4K	0.21%	34
2015 Q1	$365K	Sell	11,067 -762	-6%	-$24.2K	0.2%	35
2014 Q4	$349K	Buy	11,829 +762	+7%	+$21.8K	0.18%	40
2014 Q3	$310K	Hold	11,067	–	–	0.17%	43
2014 Q2	$312K	Sell	11,067 -4,142	-27%	-$118K	0.16%	49
2014 Q1	$463K	Sell	15,209 -1,392	-8%	-$41.5K	0.25%	41
2013 Q4	$482K	Sell	16,601 -3,001	-15%	-$87.3K	0.26%	43
2013 Q3	$534K	Sell	19,602 -2,637	-12%	-$71.8K	0.32%	47
2013 Q2	$591K	Buy	+22,239	New	+$614K	0.38%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Family Capital Trust's PFE Position: Q3 2023 in Review

Family Capital Trust sold out of Pfizer (PFE) in Q3 2023, closing a stake of 7,200 shares — an estimated $264K sold.

Family Capital Trust first reported a position in PFE in Q2 2013 and held it in 41 quarters. The position peaked at $591K in Q2 2013. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Family Capital Trust reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Family Capital Trust sold 7,200 Pfizer shares in Q3 2023, an estimated $264K.
Family Capital Trust first reported a position in Pfizer in Q2 2013 and held it in 41 quarters.
Family Capital Trust's Pfizer position peaked at $591K in Q2 2013.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Family Capital Trust's 13F filing for Q3 2023, filed 27 Oct 2023.